Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
0.4048
-0.1035 (-20.36%)
Mar 31, 2025, 2:30 PM EDT - Market open
Sensei Biotherapeutics Employees
Sensei Biotherapeutics had 28 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
28
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,077,036
Market Cap
10.18M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 28 | 0 | - |
Dec 31, 2022 | 28 | -28 | -50.00% |
Dec 31, 2021 | 56 | 24 | 75.00% |
Dec 31, 2020 | 32 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SNSE News
- 3 days ago - Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress - GlobeNewsWire
- 3 days ago - Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors - GlobeNewsWire
- 7 weeks ago - Sensei Biotherapeutics to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 2 months ago - Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones - GlobeNewsWire
- 4 months ago - Sensei Biotherapeutics to Participate in Citi's 2024 Global Healthcare Conference - GlobeNewsWire
- 4 months ago - Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 5 months ago - Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences - GlobeNewsWire
- 7 months ago - Sensei Biotherapeutics to Present Preclinical Data on SNS-103 at the CRI-ENCI Eighth International Immunotherapy Conference - GlobeNewsWire